Individuals Coming Off Anti-Obesity Medications Regain Pounds Four Times Faster Compared to Dieters

New research indicates that people who stop using new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who stop traditional lifestyle regimens.

Findings released in a major health publication points out that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"People purchasing such treatments must be cognizant of the danger of fast weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a reversion to starting mass in about a year and a half.

Comparing Therapies

The research, which looked at dozens of trials involving over 9,000 of patients, compared the effects of the injectable medications with other pills.

Scientists emphasize that people who shed pounds through diet and exercise usually see a less rapid creep back—around 0.1 kg a month—after stopping.

The Reason for the Fast Regain

Nutrition scientists suggest the mode of action of the drugs accounts for the accelerated rebound.

These medications copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication means appetite is no longer kept in check, making overeating a significant risk."

A Lifelong Disease?

The NHS advise the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.

Many experts contend that, considering the high risk of weight regain, the treatment is often ongoing.

This perspective is reinforced by pharmaceutical companies, who state that the results "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.

User Accounts

Users who have come off the jabs report a powerful resurgence of hunger.

"It felt as if something activating and you become ravenous," recalled an individual.

The struggle is worsened if users have not established sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Survey data show that millions of people in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is greater among women than males.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Finally, experts caution that while these medications are potent tools for weight loss, they are not a permanent cure and long-term success relies on ongoing behavioural changes.